Experimental cell therapy tested in patients with Tough-to-Treat cancers
Disease control
Completed
This first-in-human study tested the safety and early effectiveness of SUPLEXA, an experimental cell therapy, in adults with advanced cancers that had stopped responding to standard treatments. Forty-six participants with either metastatic solid tumors or blood cancers received w…
Phase: PHASE1 • Sponsor: Alloplex Biotherapeutics Inc • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC